Inventor · disambiguated record
Jeremy Graff
Also filed as: GRAFF JEREMY · GRAFF JEREMY R · GRAFF JEREMY RICHARD
7 granted patents·17 pending applications·40 citations·filing 2004–2024
83Inventor score
Top patents by PatentIndex Score
24 records- 0190US7425544B2Modulation of eIF4E expressionLILLY CO ELI·Filed 2004·Granted Sep 16, 2008·26 cites·16 claims
- 0286US10111901B2Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·4 cites·19 claims
- 0384US10111900B2β-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·3 cites·20 claims
- 0484US7601700B2Modulation of eIF4E expressionLILLY CO ELI·Filed 2008·Granted Oct 13, 2009·4 cites·16 claims
- 0582US2025009782A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0681US2025114392A1Beta-glucan in combination with anti-cancer agents affecting the tumor micrenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0780US8410074B2Modulation of eIF4E expressionDOBIE KENNETH W·Filed 2012·Granted Apr 2, 2013·3 cites·14 claims
- 0880US2024350528A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2023·Application pending·0 cites
- 0979US2025114391A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 1074US2023172967A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2022·Application pending·0 cites
- 1173US2022117998A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1268US2022047620A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1368US2010130589A1MODULATION OF eIF4E EXPRESSIONFREIER SUSAN M·Filed 2009·Application pending·0 cites
- 1467US2024019444A1Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 1567US2021283169A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1663US2019060350A1Beta-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1762US2019022129A1Beta-glucan immunotherapies affecting the immune microenvironmentBIOTHERA INC·Filed 2017·Application pending·0 cites
- 1862US2019060351A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1958US2013178513A1Modulation of eif4e expressionISIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2054US2011301222A1Combination therapy for the treatment of cancerGRAFF JEREMY RICHARD·Filed 2009·Application pending·0 cites
- 2153US2006281787A1Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseasesGRAFF JEREMY R·Filed 2004·Application pending·0 cites
- 2252US11815435B2Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2018·Granted Nov 14, 2023·0 cites·7 claims
- 2352US8268797B2Combination therapy for the treatment of cancerGRAFF JEREMY RICHARD·Filed 2009·Granted Sep 18, 2012·0 cites·12 claims
- 2437US2014323543A1Treatment of Prostate Cancer with eIF4E Antisense CompoundsGRAFF JEREMY RICHARD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremy Graff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →